Crohn's Disease and Colitis Trial, Recruiting (NCT06495658)

Crohn's Disease and Colitis Trial, Recruiting NCT06495658 Sponsor: University of California, Los Angeles Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT06495658 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 85 years old
You have been diagnosed with ulcerative colitis (a type of inflammatory bowel disease) confirmed by a biopsy (tissue sample test)
You are currently experiencing active symptoms, based on a symptom scoring system (confirm with trial site)
You are taking certain medicines such as anti-inflammatory bowel drugs, immune-suppressing drugs, or steroids, as long as you have not started them or changed your dose in the last 30 days
You are taking biologic therapy (a type of advanced medication for bowel disease), as long as you have not started it or changed your dose in the last 60 days
You currently take probiotics or dietary supplements, but you would need to stop taking them for the duration of the trial

Who may not be able to join:

You have previously had surgery to remove part or all of your colon
You are currently hospitalised
You urgently need abdominal surgery
You have a serious or unstable medical condition
You are currently receiving treatment for cancer
You have an active problem with alcohol or drug misuse (not including cannabis)
You are pregnant or breastfeeding
There are concerns that you may have difficulty following the trial requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06495658

Sponsor: University of California, Los Angeles

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

More information: https://clinicaltrials.gov/study/NCT06495658

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 85 years old
You have been diagnosed with ulcerative colitis (a type of inflammatory bowel disease) confirmed by a biopsy (tissue sample test)
You are currently experiencing active symptoms, based on a symptom scoring system (confirm with trial site)
You are taking certain medicines such as anti-inflammatory bowel drugs, immune-suppressing drugs, or steroids, as long as you have not started them or changed your dose in the last 30 days
You are taking biologic therapy (a type of advanced medication for bowel disease), as long as you have not started it or changed your dose in the last 60 days
You currently take probiotics or dietary supplements, but you would need to stop taking them for the duration of the trial

Who may not be able to join:

You have previously had surgery to remove part or all of your colon
You are currently hospitalised
You urgently need abdominal surgery
You have a serious or unstable medical condition
You are currently receiving treatment for cancer
You have an active problem with alcohol or drug misuse (not including cannabis)
You are pregnant or breastfeeding
There are concerns that you may have difficulty following the trial requirements

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

9 July 2024

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Clinical remission; Change in fecal calprotectin; Microbial composition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov